ISCP Best Posters 2026

In the UK, national guidelines (NICE NG238) support systematic risk assessment, lipid optimisation, and targeted intervention in high risk populations to reduce cardiovascular morbidity and mortality.  CVD remains a leading cause of premature death in England and disproportionately affects socioeconomically deprived communities. Individuals living in the most deprived areas experience markedly higher premature mortality than compared to people in more affluent areas.  Dyslipidaemia is frequently asymptomatic, and early identification in underserved populations is central to guideline-directed prevention.

This study evaluated the impact of pharmacists within a collaborative prescribing model in a General Practitioner (GP) clinic to address gaps in cardiometabolic risk factor control. Pharmacist-Supported Care (PSC) was assessed for non-inferiority to Standard-Care (SC) in achieving cardiometabolic therapeutic targets (glycaemic, lipid, and blood pressure control) through pharmacotherapy optimisation.

This 17-year experience demonstrates that high-quality, sustainable warfarin control is achievable in real-world practice through a structured prescriber–pharmacist collaborative MTAC model.

Pharmacist-led teleconsultations significantly improved lipid-lowering target attainment, accelerated glycemic control, aided smoking cessation, and reduced long-term readmissions in post-AMI patients, supported by greater dose intensification of guideline-directed medications.

CYP2C19 genetic testing identifies Non-LoF carriers who may benefit from de-escalating ticagrelor to clopidogrel, reducing bleeding events.

Notable gaps remain between knowledge and practice as well as institutional access to recommended reversal agents. Improved availability, standardised protocols, and adherence to current evidence-based guidelines are needed to optimise OAC reversal practices.

Over the last five years, 80% of cardiovascular disease (CVD) mortalities transpired in developing nations, particularly in the Middle East and Indian Subcontinent. In 2022, CVDs culminated in approximately 19.8 million demises, with myocardial infarction (MI) accountable for 9 to 10 million. Affective Disorder (AD) is frequently overlooked in the framework of MI. Investigations have substantiated a bidirectional relationship between AD and MI, with severe AD confront a 40%-60% augmented risk of developing CVD and experiencing MI. The neurocardiovascular axis is critical for maintaining homeostasis during ischemic stress. Hypoxia-Inducible Factor-1 alpha (HIF-1α) serves as a master regulator of adaptive responses in neuronal and cardiac tissues. This study identifies potent phytocompounds from traditional Ayurvedic formulations as dual system modulators using an integrated computational framework.

Post-partum patients with advanced pulmonary arterial hypertension (PAH) complicated by cardiogenic shock require prompt prostacyclin therapy. However, parenteral prostacyclins may be unavailable in resource-limited settings, necessitating alternative strategies.

The P2Y12 rs6809699 genotype was associated with higher on-treatment platelet reactivity, independent of CYP2C19 genotype, suggesting its potential as a genetic marker for clopidogrel resistance. Further studies with larger sample sizes are needed to assess its clinical utility.

This systematic review aims to synthesize current evidence on the effect of transthyretin (TTR) gene-silencing therapies in transthyretin cardiac amyloidosis (ATTR-CM) patients using advanced cardiac imaging modalities.

Angiotensin receptor neprilysin inhibitor (ARNi) is one of the four pillars for management of heart failure with reduced ejection fraction (HFrEF).  There is paucity of Indian data on the use of ARNi in the real-world settings. The aim of this study was to assess the dosage pattern and treatment persistence with ARNi in HFrEF patients.

Mesalamine is widely considered as first line treatment for maintaining remission in patient with mild-to -moderate ulcerative colitis. While treating elderly (65-85 years old patient with mesalamine,certainly cardiovascular disorders  occur  consequence as  adverse events and life threatening.

To characterise the extent and patterns of intra-individual lipoprotein(a) [Lp(a)] variability, and the independent effects of lipid-lowering therapies (LLT) on Lp(a), in a multi-ethnic Southeast Asian cohort with elevated Lp(a), where longitudinal data are sparse and guidance on repeat measurement is limited.

Cardiovascular drugs account for only ~3% of new active substances approved globally (2014–2023), with fewer than 1 in 20 novel compounds achieving regulatory approval—a rate far below oncology. This attrition reflects three critical limitations of conventional preclinical models: inter-species divergence in cardiac electrophysiology, failure to recapitulate multicellular tissue architecture and paracrine signalling, and poor fidelity of animal disease models to clinical pathophysiology. An intermediate-complexity platform preserving native three-dimensional architecture, cellular heterogeneity, and intact electromechanical function is therefore urgently required..

Heart failure (HF) following acute myocardial infarction (AMI) is a common and prognostically significant, yet the extent of HF underrecognition and its impact on guideline-directed medical therapy (GDMT) and clinical outcomes remain poorly characterised. We aimed to evaluate HF underrecognition prevalence among post-AMI patients meeting clinical HF criteria, and assess its association with GDMT prescribing patterns and 1-year all-cause mortality

Early post discharge optimization of guideline-directed medical therapy (GDMT) in heart failure with reduced ejection fraction (HFrEF) remains challenging in routine practice. While STRONG-HF supports early intensive follow-up and rapid GDMT optimization, short lead times are often not feasible in cardiology clinics.

To describe clinical outcomes of patients with heart failure with reduced ejection fraction (HFrEF) receiving sacubitril/valsartan in a real-world setting.

Guideline-recommended medical therapy (GRMT) is associated with improved clinical outcomes even after cardiac surgery. However, the extent to which GRMT is achieved at admission for postoperative cardiac rehabilitation remains insufficiently investigated. This study aimed to clarify the real-world status of disease-specific GRMT in this setting.

In Japan’s rapidly aging society, sustaining regional cardiovascular care requires both reinforcement of the medical workforce and improvement of hospital financial performance through inter-hospital collaboration. We assessed the impact of a collaborative care model implemented between a university hospital and a regional hospital.